Medicover (BATS-CHIXE:MCOVBS) - Stock Price, News & Analysis

MCOVBS Stock Overview

Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details

MCOVBS fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	4/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 50.6% below our estimate of its fair value

Earnings are forecast to grow 37.81% per year

Earnings grew by 1492.9% over the past year

Risk Analysis

Interest payments are not well covered by earnings

Shares are highly illiquid

Large one-off items impacting financial results

Medicover AB (publ) Competitors

Integrated Diagnostics Holdings

LSE:IDHC

US$225.8m

Kooth

AIM:KOO

UK£60.4m

Mediclinic International

LSE:MDC

UK£3.7b

Spire Healthcare Group

LSE:SPI

UK£875.6m

Price History & Performance

Summary of all time highs, changes and price drops for Medicover
Historical stock prices
Current Share Price	SEK 132.80
52 Week High	SEK 187.20
52 Week Low	SEK 132.80
Beta	1.47
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-47.09%
5 Year Change	57.72%
Change since IPO	117.70%

Recent updates

Shareholder Returns

	MCOVBS	GB Healthcare	GB Market
7D	0%	-3.9%	-0.3%
1Y	n/a	-24.2%	6.1%

Return vs Industry: Insufficient data to determine how MCOVBS performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how MCOVBS performed against the UK Market.

Price Volatility

Is MCOVBS's price volatile compared to industry and market?
MCOVBS volatility
MCOVBS Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.4%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.3%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: MCOVBS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MCOVBS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	45,316	Fredrik Rågmark	www.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.

Medicover AB (publ) Fundamentals Summary

How do Medicover's earnings and revenue compare to its market cap?
MCOVBS fundamental statistics
Market cap	SEK 30.48b
Earnings (TTM)	SEK 260.58m
Revenue (TTM)	SEK 21.34b

117.0x

P/E Ratio

1.4x

P/S Ratio

Is MCOVBS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCOVBS income statement (TTM)
Revenue	€1.83b
Cost of Revenue	€1.45b
Gross Profit	€374.20m
Other Expenses	€351.90m
Earnings	€22.30m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 25, 2024

Earnings per share (EPS)	0.15
Gross Margin	20.49%
Net Profit Margin	1.22%
Debt/Equity Ratio	112.3%

How did MCOVBS perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

80%

Payout Ratio

MCOVBS Stock Overview

Rewards

Risk Analysis

Medicover AB (publ) Competitors

LSE:IDHC

US$225.8m

AIM:KOO

UK£60.4m

LSE:MDC

UK£3.7b

LSE:SPI

UK£875.6m

Price History & Performance

Recent News & Updates

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Recent updates

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Dividend of €0.12 announced

Insider recently bought kr1.8m worth of stock

Dividend of €0.12 announced

Full year 2023 earnings released: EPS: €0.12 (vs €0.081 in FY 2022)

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Full year 2022 earnings released: EPS: €0.081 (vs €0.69 in FY 2021)

Full year 2022 earnings released

Medicover AB (publ) Proposes Dividend for 2022

Investor sentiment improves as stock rises 26%

Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023

Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023

Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL.

Medicover AB (publ), Annual General Meeting, Apr 27, 2023

Medicover AB (publ) (OM:MCOV B) acquired Konzilijum.

Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) acquired Kliniki Terapii Allenort Holding Sp. z o.o.

Medicover AB (Publ) Elects Anne Berner and Azita Shariati as Board Members

Full year 2021 earnings released: EPS: €0.69 (vs €0.18 in FY 2020)

General Legal Counsel recently bought kr518k worth of stock

Now 24% undervalued after recent price drop

Medicover AB (publ) Proposes Dividend for the Financial Year 2021, Expected Payable on 6 May 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Medicover AB (publ) (OM:MCOV B) acquired an unknown majority stake in Mediplus Clinic.

Chief Financial Officer recently sold kr1.4m worth of stock

Independent Director recently sold kr2.9m worth of stock

Third quarter 2021 earnings released

Insufficient new directors

Medicover AB (publ) (OM:MCOV B) acquired 70% stake in Klinikk Hanne As for €18.2 million.

Medicover AB (publ) (OM:MCOV B) acquired 88.8% stake in Sellmerdiers Aps from Liza Diers and Anette Sellmer for €13.7 million.

Chief Information Officer recently bought kr161k worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Full year 2020 earnings released: EPS €0.18 (vs €0.17 in FY 2019)

New 90-day high: kr188

Full year 2020 earnings released: EPS €0.17 (vs €0.17 in FY 2019)

Revenue beats expectations

Diagnostic Services COO Benedikt Von Braunmühl Has Decided to Leave Medinova Diagnostic Services Limited

New 90-day high: kr154

Medicover AB (publ) to Report Q1, 2021 Results on Apr 29, 2021

Medicover AB (publ) to Report Q3, 2020 Results on Nov 06, 2020

Shareholder Returns

Price Volatility

About the Company

Medicover AB (publ) Fundamentals Summary